Latest on Ratan Tata’s investment platter is a cancer therapeutic startup!
Advertisement
Advertisement
Tata has pumped money in
It has been validated in multiple cancer models.
"I have admired Ratan Tata's insights and astute assessment of technology for decades now, So I am thrilled he has invested in Invictus, which is not just developing ground-breaking innovations for cancer treatment, but is also among the very first startups based out of India to tread the path of novel discovery and biotech innovation," said Raghunath A. Mashelkar, co-founder of Invictus Oncology.
Year 2016 is going great for Tata as this was his fifth investment of this year.
Advertisement
This Delhi-based also claims it has already developed a "deep pipeline of molecules," which address a $20 billion market opportunity in the oncology space.
The investment in Invictus Oncology will add to Tata’s rapidly expanding portfolio of almost 30 investments made over the last 12-18 months.
Advertisement
- Global stocks rally even as Sensex, Nifty fall sharply on Friday
- In second consecutive week of decline, forex kitty drops $2.28 bn to $640.33 bn
- SBI Life Q4 profit rises 4% to ₹811 crore
- IMD predicts severe heatwave conditions over East, South Peninsular India for next five days
- COVID lockdown-related school disruptions will continue to worsen students’ exam results into the 2030s: study
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market